Data from that trial demonstrated prolonged survival, stable disease in some patients, and regression of epidermis tumor metastases, in addition to a favorable security profile and insufficient hepatotoxicity. We believe we have reached a significant milestone in this trial by commencing the dosing of patients with CF102. We are proud to be dealing with some of the top medical institutions in the global globe on this trial, including Tufts Medical School in the U.S. And the Rabin INFIRMARY in Israel. As we continue to screen for fresh patients, we look forward to advancing the trial towards complete enrollment, mentioned Can-Fite CEO Dr.To date the lethal stress of the bird flu virus, H5N1, offers killed 67 of the 130 people it has contaminated in Asia since 2003, mainly in Vietnam and Thailand, but it hasn’t as yet shown that it could spread conveniently among people. The other day China confirmed two even more human cases of bird flu, among which resulted in a death. Another loss of life was reported as being highly likely due to bird flu, but is not up to now confirmed.